Neurodegenerative Mitigation is the clinical strategy and physiological process aimed at slowing, halting, or reversing the progressive loss of structure or function of neurons in the central nervous system. This proactive intervention is crucial for preserving cognitive and motor function against conditions like Alzheimer’s and Parkinson’s diseases. Optimal hormonal balance, particularly the presence of neurosteroids, is a powerful endogenous mechanism for this mitigation.
Origin
A clinical and pharmacological term derived from neurology, combining ‘neurodegenerative’ (relating to the progressive decline of nervous tissue) with ‘mitigation’ (the action of reducing the severity or seriousness of something). It focuses on therapeutic counteraction of disease progression.
Mechanism
Hormones such as progesterone, allopregnanolone, and dehydroepiandrosterone (DHEA) contribute to mitigation by reducing excitotoxicity, promoting anti-inflammatory signaling in glial cells, and directly supporting mitochondrial function within neurons. The mechanism often involves enhancing the expression of neurotrophic factors and stabilizing neuronal membranes against oxidative damage, thereby fortifying the brain’s structural and functional integrity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.